Xenetic Biosciences, Inc. (XBIO)
NCM · Common · CUSIP 984015206
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for XBIO and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
984015206
Market Cap
Micro Cap
Business: Xenetic Biosciences, Inc. is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The Company is advancing cell-based therapeutics targeting the unique B-cell receptor on the surface of an individual patient’s malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a robust pipeline of therapeutic assets targeting high-value oncology indications.

Company Contact

CEO
James F. Parslow
CFO
James F. Parslow
Headquarters
945 Concord Street, Framingham, MA 01701
Phone
781-778-7720
Investor Relations
Jenene Thomas, JTC Team, LLC. · 833-475-8247 · xbio@jtcir.com
General Email
info@xeneticbio.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »